Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • SMMFollows Review: I Was Tired of Bad SMM Panels, Then I Found This One Business
  • “Game-Changer: UAE Grants Save Earth Mission PSP License for Green Finance Revolution” Business
  • Young filmmaker Manya Gadhok won accolades for short film Soulmates, stars Shruti Bapna and Jatin Sarna Entertainment
  • Edelweiss General Insurance includes the LGBTQIA+ community for its Group Health Insurance policy Business
  • Mr. Digant Sharma, CMD of Francture Brands has done Sole-tie-up with renowned Russian Refinery for Crude oil, LPG, LNG, Diesel and more Business
  • NoBroker and Sumadhura partner for an exclusive two-day Property Expo in Bengaluru Business
  • Florianópolis International Airport Concessionaire appoints SoftTech Digital Pte. Ltd to develop a Digital Twin to enable energy optimization Business
  • Apollo Micro Systems Gets Transfer of Technology for Semi-Active Laser Homing System Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • India’s leading Ayurvedic Panchakarma hospital in Hyderabad — Sai Ayush Ayurveda Hospital & Research Institute Health
  • Allen Homoeopathy: Today, every 5 seconds, Allen’s Medicine is sold or dispensed in India Health
  • Apollo Cancer Centre Hyderabad Felicitated Bone Cancer Survivors for Their Grit and Determination Health
  • India’s Pre-Budget 2024-2025: A Golden Opportunity for Global Collaboration in Defence and Healthcare Health
  • Dr. Akshay’s DentAvenue: Transforming Smiles in Chembur Health
  • Popular TV Actor Shakti Arora Features in Podcast with Renowned Dietician Dr. Harshmeet Arora Health

Recent Posts

  • Book Launch of ‘Corals Bloom Again’ by Rupinder Brar Held at Prime Ministers’ Museum & Library, New Delhi
  • Style Baazar Brings Global Football To Kolkata As Principal Partner For India’s Marquee Clashes With Brazil & Uruguay
  • SRIT India Limited IPO Opens on September 28, 2026
  • Papadmalji Agro Foods Limited IPO Opens On 29th September, Sets Price Band At Rs 69 to Rs 72 Per Share
  • Papadmalji Agro Foods Sets IPO Price Band at Rs 69–72; Issue to Open on September 29

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Cotecna Strengthens Food Testing Capabilities in India with Geo-Chem’s New Food Safety Laboratory in Navi Mumbai, India Business
  • Are Women equal if they consistently need to prove themselves, asks UNESCO Awardee and renowned Certified Yoga Psychologist, Ilashrei Anand National
  •  Boomlex Technologies Launches OneBrowsing.com at IIM Bangalore: The Ultimate Web Applications and Software AI Recommendation Engine Technology
  • BoroPlus Enters India’s Baby Care Market with ‘FromMaa’ Business
  • Parvati Jangid Suthar: The ‘Sister of Soldiers’ Named Among World’s Most Extraordinary Women by Harvard100 Lifestyle
  • CoinChapter Presents Exclusive Altcoin Market Analysis For June 2024 Finance
  • Harsh Narwani recognised as Emerging Social Media Talent by Filmfare Middle East Awards Business
  • LANXESS Q3 sales up 38.2% at EUR 2.185 billion Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme